VXRT
Vaxart Inc
Price:  
0.32 
USD
Volume:  
24,017,526.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VXRT EV/EBITDA

80.4%
Upside

As of 2026-03-15, the EV/EBITDA ratio of Vaxart Inc (VXRT) is -2.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VXRT's latest enterprise value is 120.34 mil USD. VXRT's TTM EBITDA according to its financial statements is -48.24 mil USD. Dividing these 2 quantities gives us the above VXRT EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.3x - 17.2x 14.7x
Forward P/E multiples 18.4x - 22.2x 20.5x
Fair Price (1.47) - 2.87 0.58
Upside -558.9% - 798.4% 80.4%
0.32 USD
Stock Price
0.58 USD
Fair Price

VXRT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-12 -6.42
2026-03-11 -6.71
2026-03-10 -6.73
2026-03-09 -7.01
2026-03-06 -6.43
2026-03-05 -6.27
2026-03-04 -6.64
2026-03-03 -6.54
2026-03-02 -6.80
2026-02-27 -6.97
2026-02-26 -6.55
2026-02-25 -6.26
2026-02-24 -6.35
2026-02-23 -5.49
2026-02-20 -5.04
2026-02-19 -4.73
2026-02-18 -4.63
2026-02-17 -4.72
2026-02-13 -4.81
2026-02-12 -4.80
2026-02-11 -4.89
2026-02-10 -5.04
2026-02-09 -5.18
2026-02-06 -5.20
2026-02-05 -5.35
2026-02-04 -5.39
2026-02-03 -5.55
2026-02-02 -5.21
2026-01-30 -4.94
2026-01-29 -5.21
2026-01-28 -5.51
2026-01-27 -5.58
2026-01-26 -5.65
2026-01-23 -5.79
2026-01-22 -5.70
2026-01-21 -5.70
2026-01-20 -5.96
2026-01-16 -6.09
2026-01-15 -5.60
2026-01-14 -4.65
2026-01-13 -4.47
2026-01-12 -7.01
2026-01-09 -5.88
2026-01-08 -4.00
2026-01-07 -3.41
2026-01-06 -3.15
2026-01-05 -3.07
2026-01-02 -2.91
2025-12-31 -2.74
2025-12-30 -2.79